Treatment adjustment indicators in patients with crohn's disease on infliximab maintenance therapy: Analysis of long-term claims data

被引：0
|
作者：
Loftus, E., Jr. [1 ]
Yang, M. [2 ]
Laitinen, D. [2 ]
Manthena, S. [2 ]
Chao, J. [2 ]
Mulani, P. [2 ]
机构：
[1] Mayo Clin, Rochester, MN USA
[2] Abbott Labs, Abbott Pk, IL 60064 USA
来源：
INFLAMMATORY BOWEL DISEASES | 2011年 / 17卷
关键词：
D O I：
10.1093/ibd/17.supplement1.S7
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S7 / S7
页数：1
相关论文
共 50 条
  • [31] The long-term efficacy of concomitant enteral nutritional therapy during maintenance infliximab in patients with Crohn's disease: a prospective observational trial
    Yamamoto, T.
    Nakahigashi, M.
    Shimoyama, T.
    Matsumoto, K.
    JOURNAL OF CROHNS & COLITIS, 2015, 9 : S364 - S364
  • [32] History of interrupted infliximab dosing significantly diminishes efficacy during long-term maintenance therapy in Crohn's disease
    Stein, Daniel
    Issa, Mazen
    Skaros, Susan
    Knox, Joshua F.
    Lemke, Kathryn
    Emmons, Jeanne
    Otterson, Mary F.
    Ananthakrishnan, Ashwin N.
    Binion, David G.
    GASTROENTEROLOGY, 2008, 134 (04) : A666 - A666
  • [33] Maintenance Q8 therapy of Crohn's disease with infliximab is associated with endoscopic mucosal healing in the long-term
    Schnitzler, Fabian
    Fidder, Herma
    Ferrante, Marc
    Noman, Maja
    Van Assche, Gert A.
    Hoffman, Ilse
    Vermeire, Severine
    Rutgeerts, Paul J.
    GASTROENTEROLOGY, 2008, 134 (04) : A133 - A133
  • [34] Mucosal healing of ileal lesions is associated with long-term clinical remission after infliximab maintenance treatment in patients with Crohn's disease
    Beppu, Takahiro
    Ono, Yoichiro
    Matsui, Toshiyuki
    Hirai, Fumihito
    Yano, Yutaka
    Takatsu, Noritaka
    Ninomiya, Kazeo
    Tsurumi, Kozue
    Sato, Yuho
    Takahashi, Haruhiko
    Ookado, Yuuki
    Koga, Akihiro
    Kinjo, Ken
    Nagahama, Takashi
    Hisabe, Takashi
    Takaki, Yasuhiro
    Yao, Kenshi
    DIGESTIVE ENDOSCOPY, 2015, 27 (01) : 73 - 81
  • [35] Understanding Infliximab in Crohn's Disease: The Long-Term Outcomes
    Turner, Dan
    Lev-Tzion, Raffi
    DIGESTIVE DISEASES AND SCIENCES, 2013, 58 (03) : 604 - 607
  • [36] Understanding Infliximab in Crohn’s Disease: The Long-Term Outcomes
    Dan Turner
    Raffi Lev-Tzion
    Digestive Diseases and Sciences, 2013, 58 : 604 - 607
  • [37] INFLIXIMAB IN CROHN'S DISEASE: LONG-TERM DURABILITY EXPERIENCE
    Dibb, M. J.
    Kemp, K.
    Johnson, C.
    Watson, A.
    Makin, A.
    Campbell, S.
    GUT, 2009, 58 : A94 - A95
  • [38] EFFICACY AND SAFETY OF INFLIXIMAB IN THE LONG-TERM IN CROHN'S DISEASE
    Fries, W.
    Privitera, A. C.
    Lo Presti, M. A.
    Mastronardi, M.
    Cappello, M.
    Grossi, L.
    Lauria, A.
    Principi, M.
    Della Valle, N.
    Buccianti, N.
    DIGESTIVE AND LIVER DISEASE, 2011, 43 : S134 - S134
  • [39] Long-term oral tacrolimus therapy in refractory to infliximab fistulizing Crohn's disease
    González-Lama, Y
    Abreu, L
    Vera, MI
    Pastrana, M
    Tabernero, S
    Revilla, J
    Durán, JG
    Escartin, P
    INFLAMMATORY BOWEL DISEASES, 2005, 11 (01) : 8 - 15
  • [40] Long-term response rates to infliximab therapy for Crohn's disease in an outpatient cohort
    Teshima, Christopher W.
    Thompson, Adrienne
    Dhanoa, LeRose
    Dieleman, Levinus A.
    Fedorak, Richard N.
    CANADIAN JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2009, 23 (05): : 348 - 352
12345